Advanced Biomed Inc. Common Stock
ADVB - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.24M
Close$
$1.76
41.1% downside
Current Fair Value
41.1% downsideOvervalued by 41.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.24 Million |
|---|---|
| Enterprise Value | $3.35 Million |
| Earnings per Share | $5.33 |
| Beta | -0.36 |
| Outstanding Shares | 1,252,727 |
Return
| Return on Equity | -11.78% |
|---|---|
| Return on Assets | -10.19% |
| Return on Invested Capital | -13.04% |
Valuation & Multiples
| P/E Ratio | 6.77 |
|---|---|
| PEG | 0.38 |
| Price to Sales | - |
| Price to Book Ratio | 0.43 |
| Enterprise Value to Revenue | 829.1 |
| Enterprise Value to EBIT | -2.78 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 13, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Advanced Biomed Inc. Common Stock
31 employees
CEO: Xiaomin Chen
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision onco...